U.S. FDA gives early approval to Sarepta's DMD gene therapy

The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's gene therapy for Duchenne muscular dystrophy (DMD).

from Reuters: Company News https://ift.tt/2qLbFdp
via IFTTT